ARCHIVES

FDA Purges Quality of Life Claims from Oncology Label for ESAs.

This article is from The Cancer Letter archive.

Vol. 33 No. 10 | March 16, 2007

Download PDF Visit The Full Archive

Related Articles

NCI Prepares For Intramural Program Review

June 27, 2014

Amgen Announces Cochrane Findings: ESAs Increase Risk Of On-Study Death.

October 3, 2008

In Brief: Fishman La Jolla President Emeritus, Ruoslahti Succeeds Him; Ariz. Seeks Meyskins Replacement

January 13, 1989

Tobacco Control Bill Requires Stronger Warnings

August 10, 1990

DCT Board Okay Recompetitions, Delays Decision On Clonogenic Assays

June 24, 1983

Professional Society Growth Obvious At Spring Meetings; AACR Looking To Broaden Its Base

June 5, 1987